Nanotechnology RSS feeds


ENJOY THE BENEFITS

Simply Register to GAIN ACCESS to lots more info

USER LOGIN


copyright-Nanovip 2008

tags in Event type

nanotechnology companies | nanotechnology info Earl Boysen
nanotechnology companies | nanotechnology info Hector Nicolas Suero
nanotechnology companies | nanotechnology info M.A.K. Babi

Like to Write?



NANO FACTS

...Nanometres...
nanotechnology companies | nanotechnology info Human hair 80,000 nm wide
nanotechnology companies | nanotechnology info Red blood cell 7,000 nm wide
nanotechnology companies | nanotechnology info Water molecule 0.3 nm wide
nanotechnology companies | nanotechnology info Sheet Paper 100,000 nm wide

LATEST MEMBERS

  • usharani
  • Jack Rennscheidt
  • Zossa
  • JackMast
  • nanoudhay
  • frpcad

WHO'S ONLINE

There are currently 1 user and 4 guests online.

Online users

  • jstack

  Valid XHTML 1.0 Transitional

Button for your site

MagnaMedics GmbH


   


Address: Martelenberger Weg 8
Zip: 52066

Visit this link

Phone :
+49-241-16823872

Fax :
+49-241-16823894

Based on over 30 years of scientific experience several platform technologies were developed. MagnaMedics offers MagSi (silica particles) a product line produced for analytics and diagnostics.

The therapy sector with its SensiTherm applications offers the business an enormous prospect for the future. One such application that can be singled out is the SensithermA therapy which offers a completely new and revolutionary approach to combat AIDS. The basic principle of this therapy is the selective, intracorporeal overheating of the virus and the infected cells by means of magnetic nano particles. MagnaMedics also sets the benchmark with the SensiTherm therapy for the treatment of liver tumours.

» | Edit this entry
                                                                                                                                                                                                                                                                                          
Back to previous page Go to the top of this page